Introduction tion of the downstream effector genes pointed (pnt), another ETS domain transcription factor (Klambt, 1993) , A major goal of developmental biology is to understand and blistered (pruned) , which encodes DSRF, the Drothe molecular basis of organogenesis: how organs acsophila homolog of mammalian serum response factor quire their complex three dimensional structures. This (Affolter et al., 1994; . is an especially challenging goal for organs like the lung,
In this paper, we describe another key regulator of the vascular system, and the insect tracheal system, branching called sprouty (spry). Unlike mutations in which are composed of vast branching networks of epiother tracheal genes, which result in abnormal or missthelial tubes. How is budding of new branches regulated ing branches, spry mutations cause excessive branchduring development to give rise to the complex arborizaing. The extra branches sprout from the stalks of primary tion patterns? One patterning principle operative in branches, close to the tips where secondary branches some organs is that new branches tend to sprout from normally bud. We show that this relaxation in the normal the apical or growing ends of branches, as in many apical restriction to branching results from overactivity plants. Here, we describe the molecular basis for an of the Bnl pathway. Molecular analysis shows that spry apical bias in tracheal branching and show that it results encodes a novel inhibitor that limits the range of Bnl from the interplay between an FGF inducer of branching signaling and thus restricts secondary budding to apical called Branchless and a novel antagonist we designate positions closest to the FGF signaling centers. The Spry Sprouty.
protein defines a new family of putative signaling moleThe Drosophila tracheal system is a ramified network cules that might similarly function as antagonists of FGF of epithelial tubes that delivers oxygen throughout the pathways in vertebrate development. body (Manning and Krasnow, 1993) . It arises at midembryogenesis from 20 clusters of ectodermal cells. Each * Fine branches were counted in mutant embryos stained with mAb2A12 to visualize the tracheal lumen, mAb2-161 to mark branching cells, and anti-␤-gal to distinguish homozygotes from heterozygotes carrying the 35UZ-2 TM3 lacZ balancer chromosome. The dorsal branch also gives rise to a fusion branch that was unaffected and not included in the analysis. n, number of tracheal hemisegments scored.
the ␤-galactosidase marker in tracheal cells as they are forming new branches. The original P[lacZ] insert (Pantip-2/s2683; Samakovlis et al., 1996) was a silent mutation. Three P excision alleles, designated spry ⌬5 , spry ⌬64 , and spry
⌬55
, showed excessive tracheal branching and comprised a lethal complementation group. In spry ⌬5 homozygotes, 30%-120% more branches than normal budded from the DB, LTa, LTp, GB, and VB primary branches (Figures 1D-1K ; Table 1 ). The extra branches were not distributed randomly but rather arose from the stalks of the primary branches, close to the positions where secondary and terminal branches normally bud (e.g., compare Figures 1G and 1E ). and [C]; e.g., DB1) ramify to form fine terminal (3Њ) branches (C). Others (e.g., DB2) remain as unicellular tubes that fuse to branches in neighboring hemisegments (dotted lines) to link up the tracheal network. DTa, dorsal trunk anterior; DTp, dorsal trunk posterior; VB, visceral branch; LTa, lateral trunk anterior; GB, ganglionic branch. Dorsal is up, and anterior is left in all figures unless otherwise noted. Bars, 10 m. Figure 2N ). substantially increased (from ‫02ف‬ to ‫03ف‬ in Tr5) . Fur-
The results show that spry loss of function mutations thermore, no additional dividing cells were detected in enhance all known downstream effects in this Bnl pathspry ⌬5 embryos labeled with BrdU or a string-lacZ marker way. We also found that an engineered gain of function that expresses lacZ in dividing tracheal cells. It is also condition, in which the spry gene product was overunlikely that the extra branching cells arose by suppresexpressed during embryonic stages 10-12, severely sion of cell death, because cell death does not occur blocked induction of downstream effectors and branchin normal tracheal development (Samakovlis et al., ing by Bnl ( Figures 2O and 2P ). The reciprocal is also 1996), and we found no extra branches in H99 mutant true: overexpression of Bnl can overcome the opposition embryos, which lack all normal apoptosis (White et al., of spry and induce secondary and terminal branching 1994). Rather, the extra branching cells appear to arise throughout the tracheal system . by a change in tracheal cell fate, with normally nonThus, spry behaves genetically as a competitive inhibitor branching stalk cells recruited to the branching fate. This of the Bnl pathway. interpretation is supported by the finding that secondary and terminal branch markers were inappropriately activated in prestalk cells at the same time in development spry Acts Nonautonomously in Tip Cells to Inhibit as in normal branching cells (see below). These cells also Induction of Nearby Stalk Cells followed the same developmental program as normal To determine in which cells spry ϩ function is required, secondary branch cells, forming extensive arrays of terwe carried out a genetic mosaic analysis using the FLP minal branches in the larva ( Figures 1Q and 1R ).
recombination system (Xu and Rubin, 1993) . We examined 33 mosaic GBs composed of spry Ϫ and spry ϩ cells. In the 29 clones in which just the tracheal tip cell GB1 spry Antagonizes the Bnl Pathway Secondary and terminal branching genes are induced was spry Ϫ , an ectopic branch was always present in the neighboring spry ϩ stalk cell, GB2 ( Figure 3A ). In contrast, at the ends of growing primary branches by localized expression of the Bnl FGF in surrounding tissues (Suthin three of the four clones of the opposite type in which a subset of the other stalk cells (GB2-7) were spry Ϫ , the erland et al. , 1996) . Because the ectopic branches in spry mutants are formed by the prestalk cells located GB appeared normal with no extra branches ( Figure 3B ). We presume that the single exceptional clone reprenear the cells that are normally induced to branch, the extra branches could arise from overactivity of the Bnl sents the rare situation in which a second GB cell can take on the branching fate even in the presence of wildpathway. To test whether spry ϩ functions by limiting the Bnl pathway or prevents branching in some other way, type spry function. One particularly informative spry Ϫ clone included all of the GB cells except the tip cell; we examined the effect of spry mutations on downstream effectors in the Bnl pathway that regulate the this formed a normal GB without ectopic branches. We conclude that spry ϩ is required in the tip cell and acts later branching events.
One effector tested was pnt, a downstream target of nonautonomously to inhibit branching by nearby stalk cells. Data for the DB were more limited, but they supseveral RTK pathways (O'Neill et al., 1994; Gabay et al., 1996) . pnt expression is induced by Bnl at the ends of ported the results for the GB. In all four clones in which the tip cell DB1 was spry Ϫ , nearby spry ϩ cells formed primary branches and promotes secondary and terminal branching Sutherland et al., ectopic branches ( Figure 3C ). There were two unexpected characteristics of the expressed just after tracheal development begins. The same probe identified 11 cDNA clones that correclones in which the GB1 cell was spry Ϫ . First, outgrowth of ectopic branches from GB2 and GB3 usually turned sponded to three transcript classes of a single gene ( Figure 4A ). We determined that these cDNAs represent away from the ventral nerve cord (VNC) ( Figure 3A) , whereas in spry Ϫ embryos the extra branches normally the spry gene. First, in situ hybridizations with the cDNAs as probes detected an RNA expression pattern that corentered the VNC (Figures 1J and IK) . This indicates that the remaining spry ϩ cells in the mosaic individuals responded precisely to the lacZ expression pattern in the three spry enhancer trap lines (see below). Second, somehow influence tracheal pathfinding. Second, we noticed that growth of the normal branch from a spry Ϫ all eight spry alleles have lesions in the identified transcription unit. In spry ⌬5 and spry ⌬64 , the 5Ј exon common GB1 cell sometimes appeared to be slowed when nearby cells (GB2-7) were spry ϩ . This suggests that to all splice forms was deleted ( Figure 4A ), and in the other excision allele (spry ⌬55 ) there was a complex respry ϩ might also have a cell-autonomous function that protects it from the inhibitory effects of its spry ϩ neigharrangement that included this exon (data not shown). Sequence analysis revealed nonsense or frameshift mubors (see Discussion).
tations in all five EMS alleles that would produce truncated polypeptides lacking all or most of the conserved spry Encodes a Putative Secreted Protein with a Conserved Cysteine-Rich Motif protein motif ( Figure 4C ). Finally, Spry immunoreactivity was absent in the spry ⌬5 mutant (see below). Genomic DNA flanking a spry P[lacZ] insertion was isolated by plasmid rescue and used to probe Northern Nucleotide sequencing of cDNAs identified a single long open reading frame that predicts a 591-residue (63 blots of embryonic RNA (Figures 4A and 4B) . A set of 3.2-4.4 kb mRNAs was detected that began to be kD) polypeptide ( Figure 4C ). Its most striking feature is Spry in embryos. However, when Spry was overexpressed in the developing tracheal system using the GAL4/UAS system, Spry staining was found at the plasma membrane and generally colocalized with that of a control transmembrane protein ( Figures 5A-5C ). This suggests that Spry is a membrane-associated protein or a secreted protein that remains close to the Spryexpressing cells. Spry also localized to the plasma mem- neurons ( Figure 5G ), oenocytes (see Figure 6C) , and, later, in the eye imaginal disc (S. K. et al., unpublished data) .
Tracheal expression was first detected in the primary a 124-residue cysteine-rich region (22 cysteines), which branches as they begin to bud, and it was maintained is flanked by N-and C-terminal cysteine-free regions at high levels at the ends of branches in cells that go that contain many stretches of repeated or alternating on to form secondary and ultimately terminal branches, amino acids. There are eight potential N-linked glycosylconsistent with the genetic mosaic analysis. In the DB, ation sites. There is a predicted signal peptide near spry was expressed at stages 12 and 13 in the DB tip the N terminus but no clear transmembrane domains, cells (DB1, 2) and less intensely in the trailing cells DB3 suggesting that Spry protein may be secreted. and DB4 (Figures 5H and 5I) . The tip cells soon begin to An NCBI BLAST search of the combined databases separate from each other and form discrete secondary did not detect any closely related proteins. However, a branches. After stage 13, spry was expressed most search of the expressed sequence tag (dbEST) database strongly in DB1 and ultimately in this cell alone, the only identified three human homologs designated h-Sprouty1, one that continues to branch ( Figures 5J and 5K ). h-Sprouty2, and h-Sprouty3. We determined a complete coding sequence of h-Spry2 and a partial sequence of h-Spry1 from overlapping cDNAs. The h-Spry2 sespry Expression Is Induced by the Bnl Pathway quence encodes a 315-residue (35 kD) polypeptide (Fig- The tracheal cells that express spry are located very ure 4D). It contains a cysteine-rich domain, which is close to the small clusters of epidermal and mesodermal highly conserved with Spry (51% identity, with 21 of the cells that express Bnl (see Sutherland et al., 1996 ; sche-22 Spry cysteines conserved), and two additional short matized in Figure 6A ), and the spry expression pattern stretches of similarity to Spry in the N-terminal region is very similar to that of pnt and other genes induced but no predicted signal peptide. h-Spry1 and h-Spry3 by Bnl . These observations also show strong conservation of the cysteine-rich dosuggested that spry might also be induced by the Bnl main, with 51%-70% identity to other family members pathway. Consistent with this, in bnl and btl mutants, in the available sequences. spry was not expressed or was expressed only weakly ( Figure 6C and data not shown). Furthermore, when Bnl was ubiquitously expressed, spry turned on at high levSpry Protein Localizes to the Plasma Membrane We prepared affinity-purified antisera to full-length Spry els throughout the tracheal system ( Figure 6D ). The downstream effector pnt was also required for spry exprotein and to N-and C-terminal fragments. These antisera detect Spry in eye imaginal discs where spry also pression ( Figure 6E ), and spry expression was activated outside its normal expression domain when pnt P1 profunctions, and they are specific for Spry because the staining is absent in spry ⌬5 mutants (S. K. et al., unpubtein was ubiquitously expressed ( Figure 6F ). Consistent with this, pnt spry double mutants display the same lished data). Unfortunately, none of the antisera were sensitive enough to reproducibly detect endogenous tracheal phenotype as the pnt mutant alone (data not shown). These results show that spry expression is inprimary branches by patches of Bnl expression located just ahead of the growing branches. In spry mutants, duced by the signaling pathway that it inhibits. Spry limits induction of its own gene, just as it limits induction the prestalk cells located at a somewhat greater distance from the Bnl signaling centers expressed all of of other genes by Bnl, as shown by the broadened expression domain of a spry-lacZ marker in a spry Ϫ backthe known Bnl effectors and were induced to bud like the normal secondary branch cells. Thus, spry ϩ limits ground ( Figure 2C) for proper patterning. Overexpression of Bnl overcomes expressed in bnl or btl mutants, and its expression was turned on throughout the tracheal system by ubiquitous the inhibitory effects of Spry, inducing secondary and terminal branches everywhere in the tracheal system expression of Bnl. Thus, bnl and spry comprise a negative feedback circuit that is finely tuned to allow only . Conversely, we found that overexpression of Spry during embryonic stages 10-12 preshort range signaling by Bnl. vented induction of secondary and terminal branches. Even small alterations in the levels of these antagonistic How Does Spry Antagonize Bnl Signaling? Given the competitive genetic interactions and that both signals can be significant, as sporadic ectopic branches are observed in individuals carrying an extra copy of appear to be membrane-associated or secreted proteins, the simplest biochemical model is that Spry comthe bnl gene (J. Jarecki and M. K., unpublished data).
Our molecular epistasis experiments show that the petes with Bnl for binding to the Btl receptor or that it restricts receptor activation in some other way, such as antagonistic signals are integrated in an unusual regulatory circuit ( Figure 6G ). The most unusual feature of the by binding Bnl and limiting its diffusion. It is also possible that Spry has its own receptor. The short-range inhibicircuit is that expression of the antagonist is activated by the signaling pathway that it inhibits: spry was not tory action of Spry is reminiscent of lateral inhibitory cells that express highest levels of the inhibitor. Although this is a consequence of the induction of spry expression by the Bnl pathway ( Figure 6G ), it is unclear how expression of spry and other effectors is maintained once Spry protein is present. Perhaps high levels of Bnl simply outcompete high levels of Spry. Alternatively, there may be special mechanisms that allow Spryexpressing cells to escape their own inhibitory effect, as suggested by the possible cell autonomous function of spry noted in the genetic mosaic analysis.
Spry Defines a New Family of Putative Growth Factor Antagonists
Antagonists of several major signaling pathways have been identified recently. Like Spry, each of these appears to play an important role in developmental patterning by limiting the range of signaling by the cognate inducer. Several, including Chordin/SOG (Piccolo et al., 1996) and Noggin (Zimmerman et al. 1996) , antagonize signaling by TGF-␤ family members and thereby promote neural development or restrict dorsalization of the ectoderm. Similarly, secreted Argos protein limits EGF signaling during ventral embryonic patterning and eye (Lee et al., 1996; Sutherland et al., 1996) , provides a molecular basis for patterning of secondary bud sites we showed that Spry counteracts the MAP kinasedependent degradation of Yan.
in inducer is limited by Spry.
Terminal-1 (pruned/DSRF), -2, -3, and -4 Samakovlis et al., 1996) broad domain along the distal half of the growing primary branch, and secondary budding is induced from
Immunostaining and In Situ Hybridization of Embryos
the tip half way down the stalk of the branch (Sutherland Embryos were fixed and stained with antibodies as described (Saet al., 1996) . The Spry feedback circuit is operative, but makovlis et al., 1996) . Other antibodies used were mAb2-161 (used here it prevents secondary budding at the base of the at 1:1000 dilution) to DSRF (from M. Gilman), mAb A2 8B12 to Yan branch. Bnl can also direct exclusively lateral budding
(1:5, from I. Rebay and G. Rubin), and mAbC17.9C6 to Notch (1:3000, from S. Artavanis-Tsakonas). Biotin-, Cy5-, Cy3-, and FITC-conjuwhen expressed at the side of a primary branch, and gated secondary antibodies (Jackson) were used at 1:300. BrdU here, too, Spry restricts the budding zone. The key point and TUNEL staining were done on spry proteins were purified by glutathione affinity chromatography and A number of branching inhibitors have been discovinjected into rabbits and mice (Josman Labs). Antisera were affinityered recently in mammalian systems, and several have purified using the full-length GST-Spry fusion coupled to agarose received considerable attention because they can strikbeads and then preabsorbed overnight at 4ЊC against fixed embryos ingly suppress tumor growth by blocking angiogenesis (0-2 hr old) and used at approximately 1:1000 dilution. In situ hybridization of whole-mount embryos (Tautz and Pfeifle, (Hanahan and Folkman, 1996 complex branched structures, such as the vascular system and lungs, are likely to be patterned by a balance
Genetic Mosaic Analysis
between localized inducers and inhibitors of branching
The spry ⌬5 mutation was recombined onto the left arm of an FRT- (Wolpert, 1983) . Given the extensive evolutionary concontaining third chromosome from strain 80-w ϩ (Xu and Rubin, servation of signaling pathways and patterning mecha-1993), as was the tracheal lacZ enhancer trap marker 1-eve-1. Emnisms and the prominent role of FGFs as branching bryos of genotype hsFLP; spry ⌬5 , FRT / 1-eve-1, FRT were reared at 25ЊC, heat-shocked twice at 37ЊC for 20 min at 5 and 6 hr after inducers in mammals, perhaps some of the known inhibegg lay to express FLP recombinase, and returned to 25ЊC for 10 hr.
itors or the Spry homologs described here will be found Embryos were stained with mAb2A12 and an anti-␤-galactosidase to pattern mammalian organs in a similar manner as antiserum; spry ⌬5 /spry ⌬5 clones were identified as tracheal cells that Spry.
did not express ␤-galactosidase. Clones were found in approximately 12% of embryos of the correct genotype. DB and GB clones were examined under DIC optics for extra cytoplasmic extensions Experimental Procedures and branches. Only a small number of clones were found in which GB2-7 cells did not express ␤-galactosidase, presumably because Fly Strains and Genetics these cells are crowded together making it difficult to distinguish The Pantip-2 enhancer trap lines (s2683, s1814, 1(3)9143) contain individual cells that do not express the marker. P[lacZ] inserts at 63D1,2 . s2683 and s1814, generated in M. Scott's lab, contain a P[lacZ, w ϩ ] element (Bier et al., 1989) . Both are homozygous viable with normal tracheal branching.
Molecular Biology
Genomic DNA from strain spry 2683 was digested with BamHI or EcoRI 1(3)9143 (Spradling et al., 1995 ) is a viable P[lacZ, ry ϩ ] insertion, but the chromosome carries a separate lethal mutation. Excisions of for plasmid rescue in Escherichia coli. An 8 kb HindIII/BamHI fragment (Ϫ0.6 to ϩ7.4 kb on the genomic map) obtained from BamHIs2683 were generated by crossing in a third chromosome carrying ⌬2-3 to supply transposase. One hundred white-eyed (w Ϫ ) males rescue plasmid pNH6001 was used to screen approximately 10 5 phage from a Drosophila genomic library in EMBL3 (from J. Tamkun). from independent excision events were isolated and established as
